Bcl6 plays a role in the generation and maintenance of memory CD8 1 T cells. We analyzed here a role for Bcl6 in the generation of long-term memory CD4 1 T cells. Naive CD45RB 1 CD4
Introduction
Molecular mechanisms involved in the generation of immune memory cells are largely unknown and their elucidation is the key to design strategies to control the generation of immunity. Many factors are involved in the generation of immune memory cells, including memory B cells, CD4
+ T cells and CD8
+ T cells (1) (2) (3) (4) (5) (6) , and each factor controls the generation of each lineage of memory cells. However, no general factors for the generation of immune memory cells have been demonstrated. We have recently demonstrated that the proto-oncogene Bcl6 is essential for the generation of high-affinity memory B cells in germinal centers (7, 8) and also controls the generation and maintenance of antigenspecific and lymphopenia-induced memory CD8 + T cells (9, 10) . Thus, Bcl6 may be one of the general factors involved in the generation of immune memory cells although the role for Bcl6 in the generation of memory CD4 + T cells has never been reported.
The human proto-oncogene Bcl6 has been identified from chromosomal breakpoints involving 3q27 in diffuse large B cell lymphomas (11) (12) (13) . The Bcl6 gene encodes a 92-to 98-kDa nuclear phosphoprotein (14, 15) that contains the BTB/POZ domain in the NH 2 -terminal region and Krü ppeltype zinc finger motifs in the COOH-terminal region (11) (12) (13) 16) . Since the NH 2 -terminal half of Bcl6 can bind to silencing mediator of retinoid and thyroid receptor proteins which can recruit histone deacetylase (17, 18) , Bcl6 can function as a sequence-specific transcriptional repressor (19) (20) (21) (22) (23) (24) . Some of the target genes for Bcl6 in T cells (25) and germinal center B cells (26) have been identified. Bcl6 is ubiquitously expressed in various tissues, including mature CD4 + T cells (16) , and all hematopoietic lineages, including mature lymphocytes, can develop in Bcl6-deficient mice (16) . Thus, we studied the role for Bcl6 in the generation of memory CD4 + T cells, especially long-term memory CD4 + T cells, using Bcl6-deficient CD4 + T cells from DO11.10 transgenic mice. After mice are immunized with antigen in vivo, naive antigenspecific CD4
+ T cells resided in secondary lymphoid tissues proliferate and differentiate into effector CD4 + T cells which migrate to lungs and liver within 10 days after immunization. Long-term memory CD4
+ T cells can be generated from effector CD4
+ T cells 4 weeks after immunization (27, 28) . IFN-c-producing effector CD4
+ T cells are short-lived and long-term memory CD4
+ T cells can be generated from IFNc-non-producing CD45RB À , CD62L + or IL-7Ra + effector CD4 + T cells (5, 6, 29) . But the mechanisms of generation and maintenance of IFN-c-non-producing effector CD4 + T cells are not unknown. We show here that Bcl6-deficient effector CD4
+ T cells were normally generated until 3 weeks after immunization. However, IFN-c-non-producing Bcl6-deficient effector CD4
+ T cells were not maintained in the spleen, lungs and liver for >4 weeks after immunization. Furthermore, the number of apoptotic cells in Bcl6-deficient CD4 + T cells was larger than that in wild-type CD4 + T cells at the effector phase and the late effector phase. Thus, Bcl6 in CD4
+ T cells plays a role in protection of memory precursor CD4 + T cells from apoptosis and may involve in survivability of long-term memory CD4 + T cells.
Methods

Animals
BALB/c mice were purchased from Japan SLC Co. Ltd (Hamamatsu, Japan). Bcl6-deficient mice (7) were backcrossed to BALB/c mice >10 generations and crossed to the DO11.10 transgenic mice, which express the TCR specific for ovalbumin peptide (OVA) OVA 323-339 in context of the MHC class II molecule I-A d (30) . The TCR can be detected by anti-KJ1.26 antibody (30) . These mice were maintained under specific pathogen-free conditions in the animal center of Chiba University School of Medicine.
Flow cytometric analysis
Single cells were stained with various mAbs as follows: 10 6 cells were first blocked with unconjugated anti-CD32/16 (2.4G2, BD PharMingen, San Diego, CA, USA), followed by incubation with biotinylated antibodies and then incubated with directly conjugated antibodies and streptavidine-PerCP (BD PharMingen). These cells were analyzed on a FACSCalibur. The following antibodies were used for staining: CD4 (RM4-1)-allophycocyanin, CD44 (IM7)-PE, CD62L (MEL-14)-FITC, CD62L-PE, CD62L-biotin, CD45RB (16A)-FITC, CD45RB-PE, CD127 (B12-1)-biotin, CD132 (JORO50)-PE (BD PharMingen), annexin V-biotin (Bender MedSystems, San Bruno, CA, USA), KJ1.26-FITC (a gift from Taki, Shinshu University, Japan) and KJ1.26-biotin (a gift from Nakayama, Chiba University, Japan). ) and anti-IL-4 mAb (11B11; 25% culture supernatant) for T h 1-skewed condition (31) . For T h 2-skewed condition, CD4
+ T cells were stimulated as above in the presence of IL-2 (25 U ml À1 ), IL-4 (100 U ml
À1
) and anti-IFN-c mAb (R4.6A2; 25% culture supernatant) (31) .
Adaptive transfer of CD4 + T cells
Sorted splenic CD45RB + CD4 + T cells (5 3 10 6 ) from DO11.10 transgenic mice were transferred intravenously into BALB/c mice. These mice were injected intravenously with OVA (OVA 323-329, 100 lg) plus LPS (25 lg) on the next day of transfer (27) .
Intracellular staining
Immunized BALB/c mice transferred with CD4 + T cells were re-stimulated with OVA (OVA 323-329 , 100 lg) intravenously 10 days after the primary immunization. Spleen, lungs and liver were isolated from the mice 2 h after re-stimulation and then minced to make a single-cell suspension. These cells were incubated in medium supplemented with collagenase (1 mg ml À1 ) and monensin (2 lM) for 20 min at 37°C. After washing the cells with PBS, these cells were stained with various antibodies for surface staining and then subjected to intracellular staining for IFN-c (anti-IFN-c-PE, BD PharMingen), using the CytoFix/Cytoperm kit (BD PharMingen), according to the manufacturer's instructions. In indicated experiments, spleen cells from immunized mice or cultured cells were re-stimulated with OVA (OVA 323-329 , 10 lM) for 6 h, and then these cells were subjected for intracellular staining. For bromodeoxyuridine (BrdU) analysis, immunized mice were injected with BrdU intra-peritoneally and spleen cells were harvested 3 h after injection. These cells were stained with various antibodies for surface staining and then subjected to intracellular staining for BrdU (anti-BrdU-FITC, BD PharMingen) according to the manufacturer's instructions.
Proliferation assay
Spleen cells from immunized mice were stimulated with OVA (OVA 323-329 , 10 lM) and cultured for 7 days using complete medium supplemented with IL-7 (10 ng ml À1 ; PeproTech EC). Live cell numbers were counted under a microscope after staining with trypan blue (Invitrogen Corporation, Auckland, New Zealand).
Statistical analysis
Statistical analysis was made using unpaired t-test. P values <0.05 were considered to be significant. Bcl6 for memory CD4 + T cell generation 429 4 weeks after immunization (Fig. 1D) . These results indicate that Bcl6 in CD4 + T cells is essential for the generation of long-term memory CD4 + T cells.
A role for Bcl6 in the generation of effector CD4 + T cells in vitro and in vivo T h 1/T h 2 skewing of naive CD4 + T cells affects the differentiation of long-term memory CD4
+ T cells (29) . Thus, a role for Bcl6 in the generation of T h 1 and T h 2 cells was examined in vitro. Naive Bcl6-deficient and wild-type CD4 + T cells from DO11.10 transgenic mice after labeled with CFSE were cultured under either T h 1-or T h 2-skewed condition for 4 days. IFN-c or IL-4 production in those CD4
+ T cells was analyzed by FACS. As shown in Fig. 2 (Fig. 3B) .
Proliferation capacity and cell death were examined using BrdU incorporation and annexin V staining of KJ1.26 + CD4 + T cells in the spleen, respectively. Fig. 3 + CD4 + T cells proliferated 10-fold within 7 days after re-stimulation ( Fig. 5A and B) . Although the number of IFN-c-producing cells in Bcl6-deficient KJ1.26 + CD4 + T cells was compatible to that in wild-type 
Discussion
Bcl6 plays an important role in the generation and maintenance of memory cells, especially central memory CD8 + T cells (9, 10) and memory B cells with high affinity in germinal centers (8, 16) . In this present study, we also showed the essential role for Bcl6 in the generation of long-term memory CD4 + T cells. The adoptive transfer experiments revealed that Bcl6-deficient KJ1.26 + CD4 + T cells could be identified in the spleen, lungs and liver of transferred BALB/c mice at least 3 weeks after immunization. However, no Bcl6-deficient KJ1.26 + CD4 + T cells could be observed in any organs examined of transferred BALB/c mice 4 weeks after immunization. Long-term memory T cells can be detected in the spleen of mice between 3 and 6 weeks after immunization by the kind of antigens and adjuvants (6, 27) . These results suggest that Bcl6 expression in CD4 + T cells is essential for the generation of long-term memory CD4 + T cells. IL-7 signals are essential to maintain effector CD4 + T cells and to promote generation of memory CD4 + T cells after immunization (5, 6) . Then, we examined IL-7 receptor a and common c expression on Bcl6-deficient KJ1.26 + CD4
+ T cells at various time points after stimulation. These levels were comparable to those on wild-type KJ1.26 + CD4 + T cells at any time points examined. Although the number of CD62L + CD4 + T cells in the spleen of wild-type mice is more than that of IL-7-deficient mice at the late effector phase after immunization (5, 6) , the percentage of CD62L + cells in Bcl6-deficient effector CD4 + T cells was similar to that in wild-type effector CD4 + T cells. These results suggest that Bcl6 does not affect IL-7 signals required for the generation of long-term memory CD4 + T cells. Long-term memory T cells develop from effector T cells (28) , and IFN-c + effector cells are short-lived and do not efficiently develop into long-term memory T cells (29) . Although there was a significant difference in the number of IFN-c-producing Data are presented as the mean 6 SD from three independent experiments (*P < 0.05, **P < 0.01 and ***P < 0.005). Data are presented as the mean 6 SD from three independent experiments (NS, not significant, *P < 0.05, **P < 0.01 and ***P < 0.005).
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